🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested
The purpose of this study is to test whether the group B meningitis vaccine...
Status
Completed
Location
University of North Carolina Health Care
Start Date
2019-10-09
Trial ID
NCT04094883
Treatments Being Tested
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
Objectives: Efficacy of a meningococcal vaccine against Neisseria gonorrhoe...
Status
Active Not Recruiting
Location
Stanley Ho Centre for Emerging Infectious Diseases
Start Date
2023-05-04
Trial ID
NCT05766904
Treatments Being Tested
The bacterium (germ) Neisseria meningitidis causes meningitis and blood poi...
Status
Completed
Location
Oxford Vaccine Group
Start Date
2012-12
Trial ID
NCT01593514
Treatments Being Tested
This multicentre, parallel group, block randomised clinical trial aims to i...
Status
Completed
Location
Centre for Clinical Vaccinology and Tropical Medicine
Start Date
2015-08
Trial ID
NCT02482636
The North Carolina Immunization Branch will evaluate the use of the CDC pro...
Status
Completed
Location
Cervical Cancer-Free North Carolina
Start Date
2011-04
Trial ID
NCT01544764
Treatments Being Tested
This study was aimed to explore safety and immunogenicity of two formulatio...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00381615
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested